BGC > Product Search > 6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo[2,1-b]thiazole dihydrochloride | 72873-74-6

Molecular Formula: C16H12FN3S
Molecular Weight: 297.36
Hazard Symbols: Xi
WGKGermany: 3

Molecular Formula: C16H12FN3S
Molecular Weight: 297.36
Hazard Symbols: Xi
WGKGermany: 3

Description :
SKF-86002 is a p38 MAP kinase inhibitor, the IC50 is 0.1 - 1 μM. It potently inhibits LPS-induced IL-1 and TNF-α production in human monocytes, the IC50 is1 μM. It also acts as an inhibitor of both cyclooxygenase (COX) and 5-lipoxygenase (5-LO). In vitro: SKF-86002 inhibited prostaglandin H2 synthase activity, the IC50 is 120 mM as well as prostanoid production by rat basophilic leukemia cells, the IC50 is mM and its sonicate ( the IC50 is 100 mM and human monocytes (the IC50 is 1 mM. It inhibited the generation of dihydroxyeicosatetraenoic acid and 5-hydroxyeicosatetraenoic acid by a high speed supernatant fraction of RBL-1 cells (the IC50 is 10 mM). It blocked superoxide anion production in response to FMLP and reduced adhesion and chemotaxis in response to PAF or FMLP.

• Molecular Weight :297.36
• Boiling Point :476.1±55.0 °C | Condition: Press: 760 Torr
• Melting Point :189-192ºC
• Purity :> 98%

Molecular Formula :
C16H12FN3S
Canonical SMILES :
C1CSC2=NC(=C(N21)C3=CC=NC=C3)C4=CC=C(C=C4)F
InChI :
InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2
InChIKey :
YOELZIQOLWZLQC-UHFFFAOYSA-N
Solubility :
10 mM in DMSO
Appearance :
Off-white Solid
Application :
SKF-86002 could potently inhibit LPS-induced IL-1 and TNF-α production in human monocytes. It acts as an inhibitor of both cyclooxygenase and 5-lipoxygenase.
Storage : 2-8ºC
Synonyms :
SKF-86002; SKF 86002; SKF86002. 6-(4-fluorophenyl)-5-(4-pyridyl)-2,3-dihydroimidazo[2,1-b]-thiazole; 4-(4-Pyridyl)-5-(4-fluorophenyl)-2,3-dihydro-1-thia-3a,6-diazapentalene

More details are to be found here

Description :
SKF-86002 is a p38 MAP kinase inhibitor, the IC50 is 0.1 - 1 μM. It potently inhibits LPS-induced IL-1 and TNF-α production in human monocytes, the IC50 is1 μM. It also acts as an inhibitor of both cyclooxygenase (COX) and 5-lipoxygenase (5-LO). In vitro: SKF-86002 inhibited prostaglandin H2 synthase activity, the IC50 is 120 mM as well as prostanoid production by rat basophilic leukemia cells, the IC50 is mM and its sonicate ( the IC50 is 100 mM and human monocytes (the IC50 is 1 mM. It inhibited the generation of dihydroxyeicosatetraenoic acid and 5-hydroxyeicosatetraenoic acid by a high speed supernatant fraction of RBL-1 cells (the IC50 is 10 mM). It blocked superoxide anion production in response to FMLP and reduced adhesion and chemotaxis in response to PAF or FMLP.

• Molecular Weight :297.36
• Boiling Point :476.1±55.0 °C | Condition: Press: 760 Torr
• Melting Point :189-192ºC
• Purity :> 98%

Molecular Formula :
C16H12FN3S
Canonical SMILES :
C1CSC2=NC(=C(N21)C3=CC=NC=C3)C4=CC=C(C=C4)F
InChI :
InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2
InChIKey :
YOELZIQOLWZLQC-UHFFFAOYSA-N
Solubility :
10 mM in DMSO
Appearance :
Off-white Solid
Application :
SKF-86002 could potently inhibit LPS-induced IL-1 and TNF-α production in human monocytes. It acts as an inhibitor of both cyclooxygenase and 5-lipoxygenase.
Storage : 2-8ºC
Synonyms :
SKF-86002; SKF 86002; SKF86002. 6-(4-fluorophenyl)-5-(4-pyridyl)-2,3-dihydroimidazo[2,1-b]-thiazole; 4-(4-Pyridyl)-5-(4-fluorophenyl)-2,3-dihydro-1-thia-3a,6-diazapentalene

More details are to be found here